Alkaline Phosphatase, Tissue-Nonspecific Isozyme (ALPL) Antibody (FITC)

Este producto es parte de ALPL - Alkaline phosphatase tissue-nonspecific isozyme
Alkaline Phosphatase, Tissue-Nonspecific Isozyme (ALPL) Antibody (FITC)
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Alkaline Phosphatase, Tissue-Nonspecific Isozyme (ALPL) Antibody (FITC)
Category
Primary Antibodies
Provider
Abbexa
Reference
abx106534

Description

Alkaline phosphatase, tissue-nonspecific isozyme Antibody (FITC) is a Rabbit Polyclonal antibody against Alkaline phosphatase, tissue-nonspecific isozyme conjugated to FITC.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Alkaline Phosphatase, Tissue-Nonspecific Isozyme (ALPL)
Immunogen: Recombinant human Alkaline phosphatase, tissue-nonspecific isozyme protein (28-501AA).
Host
Rabbit
Reactivity
Human
Detection Method
Laser Line: 488
Excitation/Emission: 499/515
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P05186
Gene ID
249
NCBI Accession
NP_000469.3, NM_000478.5
OMIM
146300
Alias
AP-TNAP,TNS-ALP
Background
Antibody anti-ALPL
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

Alkaline phosphatase, tissue-nonspecific isozyme (ALPL) is an enzyme encoded by the ALPL gene in humans. It is also commonly known as tissue-nonspecific alkaline phosphatase (TNAP). ALPL is a type of alkaline phosphatase found in bone, liver, kidney, and intestine. ALPL plays a crucial role in bone mineralization and is involved in the regulation of phosphate metabolism. It catalyzes the hydrolysis of phosphate esters in an alkaline environment, leading to the release of inorganic phosphate. In bone tissue, ALPL is primarily expressed by osteoblasts, where it helps in the mineralization process by generating inorganic phosphate ions, which are essential for the formation of hydroxyapatite crystals, the main component of bone mineral. Deficiencies or mutations in the ALPL gene can lead to a rare genetic disorder known as hypophosphatasia (HPP). HPP is characterized by defective bone mineralization, resulting in weak and soft bones, skeletal abnormalities, and a range of other symptoms depending on the severity of the condition.